Bank of New York Mellon’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $700K | Buy |
164,292
+32,298
| +24% | +$138K | ﹤0.01% | 3310 |
|
|
2025
Q1 | $496K | Buy |
131,994
+3,328
| +3% | +$12.5K | ﹤0.01% | 3425 |
|
|
2024
Q4 | $750K | Sell |
128,666
-3,516
| -3% | -$20.5K | ﹤0.01% | 3292 |
|
|
2024
Q3 | $1.58M | Sell |
132,182
-7,741
| -6% | -$92.4K | ﹤0.01% | 2869 |
|
|
2024
Q2 | $1.51M | Buy |
139,923
+58,622
| +72% | +$634K | ﹤0.01% | 2952 |
|
|
2024
Q1 | $920K | Sell |
81,301
-19,741
| -20% | -$223K | ﹤0.01% | 3194 |
|
|
2023
Q4 | $1.42M | Buy |
101,042
+9,235
| +10% | +$130K | ﹤0.01% | 2996 |
|
|
2023
Q3 | $1.13M | Buy |
91,807
+458
| +0.5% | +$5.66K | ﹤0.01% | 3082 |
|
|
2023
Q2 | $825K | Buy |
91,349
+79,149
| +649% | +$715K | ﹤0.01% | 3314 |
|
|
2023
Q1 | $42.3K | Hold |
12,200
| – | – | ﹤0.01% | 4214 |
|
|
2022
Q4 | $29.9K | Hold |
12,200
| – | – | ﹤0.01% | 4306 |
|
|
2022
Q3 | $34K | Sell |
12,200
-85
| -0.7% | -$237 | ﹤0.01% | 4379 |
|
|
2022
Q2 | $50K | Sell |
12,285
-75,080
| -86% | -$306K | ﹤0.01% | 4341 |
|
|
2022
Q1 | $372K | Sell |
87,365
-1,052
| -1% | -$4.48K | ﹤0.01% | 3887 |
|
|
2021
Q4 | $828K | Buy |
88,417
+6,781
| +8% | +$63.5K | ﹤0.01% | 3493 |
|
|
2021
Q3 | $2.25M | Buy |
81,636
+46,653
| +133% | +$1.29M | ﹤0.01% | 2918 |
|
|
2021
Q2 | $979K | Buy |
34,983
+2,953
| +9% | +$82.6K | ﹤0.01% | 3434 |
|
|
2021
Q1 | $1.06M | Buy |
+32,030
| New | +$1.06M | ﹤0.01% | 3294 |
|